Post Market Clinical Follow-Up KeriFuse®
NCT: NCT06546332 · ACTIVE_NOT_RECRUITING
Brief Summary
The general objective of this study is to evaluate the performances and the safety related to the KeriFuse® intramedullary arthrodesis implant and associated instrumentation used in accordance with their approved labelling and instruction for use. Performance and safety of KeriFuse® intramedullary arthrodesis implant will be established on short and middle-terms in regards to the implant life-cycle.
Frequently Asked Questions
What is Post Market Clinical Follow-Up KeriFuse®?
Post Market Clinical Follow-Up KeriFuse® is a clinical trial registered under NCT06546332. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06546332?
The current status of NCT06546332 (Post Market Clinical Follow-Up KeriFuse®) is: ACTIVE_NOT_RECRUITING.
When did Post Market Clinical Follow-Up KeriFuse® start?
Post Market Clinical Follow-Up KeriFuse® started on 2022-07-05.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.